PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
September 6, 2012 | ISSUE NUMBER 266 VOL 8

Social Media
Advancing Pharma's Social Media Listening Analytics
Big Pharma's historically tin ear for social, user-generated content online is softening despite regulatory anxiety. In the quest to better understand what patients and doctors need, pharma — thanks in part to a bevy of third-party service providers — is beginning to recognize and incorporate insights from social media into their development and commercialization programs, according to a report from IDC Health Insights
...Read more

Regulatory
FDA, AdvaMed Seek Clarity on Med Device Pre-Market Approvals
The FDA and the Advanced Medical Technology Association (AdvaMed) gave cardiovascular device manufacturers plenty to think about over the holiday weekend with information presented at an Aug. 28 workshop. The two bodies came together to explain requirements for 30-day notices and annual change reports for Pre-Market Approvals (PMAs), an important gateway to medical device access and commercialization
...Read More

Technology
Medical Journals Follow Docs to the iPad
With four in ten physicians saying they use a tablet device between patient consultations, and reporting that online medical journals are the number one destination at that time, it makes sense that journals themselves are now joining the iPad revolution ...Read More

Global
Beleaguered UK Health Secretary Replaced — by an Equally Controversial Character
The troubled UK Health Secretary Andrew Lansley has fallen on his sword, losing his position in this week's 'Cabinet reshuffle'. But his replacement could prove to be an even more controversial character
...Read more

// Bayer named current US head of Bayer Healthcare Pharmaceuticals Philip Blake as its senior Bayer representative for the US. // INC Research (Raleigh, NC) appointed Neil Ferguson as Executive Vice President, Business Development. // Teva Pharmaceutical Industries Ltd. (Jerusalem, Israel) appointed Dr. Carlo De Notaristefani as President and Chief Executive Officer of Global Operations, and Mr. Aharon (Arik) Yaari as the Executive Vice President to the newly created organization, Community and Institutional Affairs.

September 13: Healthcare Businesswomen's Association Boston Chapter Healthcare Forum: Impact of Healthcare Reform on Innovation
Boston, MA


September 20–21: 3rd Annual Forum on Strategic Distribution Planning for Specialty Products
East Brunswick, NJ


October 17–18: 2nd Annual Global Transparency Reporting Congress
Amsterdam, The Netherlands

Advertisement
Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
On-Demand Webcast
http://pharmexec.com/demand

 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook



Survey
Should FDA change the way it regulates the drug industry?

Click To Vote
 
Quick Links

Embryonic Stem Cell Research and the Taxpayer

Good Policy: The Victim of 'Good Works'?

FDA Eyes More Foreign Inspections


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |